Literature DB >> 3053559

Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile.

M Delmée1, V Avesani.   

Abstract

The susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline of 308 isolates of Clostridium difficile from various origins was determined by a disc diffusion susceptibility testing and the results were compared with the serogroup of the strains. For the five antimicrobials, there was a clear-cut separation between susceptible and resistant strains. Some correlation between resistance and serogroup was found. Almost all of the 161 isolates of serogroups A, F, G, H and X were susceptible to all antibiotics. The 32 toxigenic isolates of serogroup C were characterized by a typical resistance pattern which could be used for typing purposes. Other serogroups showed variable patterns. The review of 64 cases of antibiotic associated diarrhoea showed that these differences in susceptibility could have clinical implications: all seven cases due to clindamycin were caused by a clindamycin resistant strain of serogroup C, whereas cases associated with other antibiotics were distributed among various serogroups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053559     DOI: 10.1093/jac/22.3.325

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.

Authors:  F Barbut; D Decré; B Burghoffer; D Lesage; F Delisle; V Lalande; M Delmée; V Avesani; N Sano; C Coudert; J C Petit
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Nosocomial outbreak of Clostridium difficile diarrhea in a pediatric service.

Authors:  A Ferroni; J Merckx; T Ancelle; B Pron; E Abachin; F Barbut; J Larzul; P Rigault; P Berche; J L Gaillard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

4.  Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C.

Authors:  P van Dijck; V Avesani; M Delmée
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  Investigation of an outbreak of Clostridium difficile infection in a general hospital by numerical analysis of protein patterns by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  M Costas; B Holmes; S L On; M Ganner; M C Kelly; S K Nath
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile.

Authors:  C P Cartwright; F Stock; S E Beekmann; E C Williams; V J Gill
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients.

Authors:  F Barbut; C Depitre; M Delmée; G Corthier; J C Petit
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Identification of outbreak-associated and other strains of Clostridium difficile by numerical analysis of SDS-PAGE protein patterns.

Authors:  M Costas; B Holmes; M Ganner; S L On; P N Hoffman; M A Worsley; H Panigrahi
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

10.  Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea.

Authors:  Hanna Pituch; Alex Van Belkum; Nicole Van Den Braak; Piotr Obuch-Woszczatynski; Henri Verbrugh; Felicja Meisel-Mikołajczyk; Mirosław uczak
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.